Hepatitis C virus infection and risk of cancer: A population-based cohort study

Clinical Epidemiology

Volumn 2, Issue 1, 2010, Pages 179-186

  Omland, Lars Haukali ^a   Farkas, Dora Körmendiné ^b   Jepsen, Peter ^b,c   Obel, Niels ^a   Pedersen, Lars ^b  

^a Rigshospitalet   (Denmark)

^b Department of Clinical Epidemiology ^*  (Denmark)

^c AARHUS UNIVERSITY HOSPITAL   (Denmark)

Author keywords

Cancer; Hepatitis C virus; Non hodgkin lymphoma; Standardized incidence ratio

Indexed keywords

ADULT; AGED; ALCOHOLISM; ARTICLE; CANCER INCIDENCE; CANCER REGISTRY; CANCER RISK; COHORT ANALYSIS; CONTROLLED STUDY; DENMARK; DISEASE ASSOCIATION; DISEASE COURSE; FEMALE; FOLLOW UP; HEPATITIS C; HEPATITIS C VIRUS; HIGH RISK POPULATION; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; LIVER CANCER; LIVER CIRRHOSIS; LONG TERM CARE; MAJOR CLINICAL STUDY; MALE; MIXED INFECTION; NONHODGKIN LYMPHOMA; POPULATION RESEARCH; RISK ASSESSMENT; SMOKING; STANDARDIZED INCIDENCE RATIO; SURVIVAL TIME;

EID: 77955481506     PISSN: None     EISSN: 11791349     Source Type: Book Series    
DOI: 10.2147/clep.s10193     Document Type: Article

References (43)

1. Bruix J, Barrera JM, Calvet X, et al. Prevalence of antibodies to hepatitis C virus in Spanish patients with hepatocellular carcinoma and hepatic cirrhosis. Lancet. 1989;2:1004-1006.
2. Colombo M, Kuo G, Choo QL, et al. Prevalence of antibodies to hepatitis C virus in Italian patients with hepatocellular carcinoma. Lancet. 1989;2:1006-1008.
3. Simonetti RG, Cottone M, Craxi' A, et al. Prevalence of antibodies to hepatitis C virus in hepatocellular carcinoma. Lancet. 1989;2:1338.
4. Choo QL, Kuo G, Weiner AJ, Overby LR, Bradley DW, Houghton M. Isolation of a cDNA clone derived from a blood-borne non-A, non-B viral hepatitis genome. Science. 1989;244:359-362.
5. Amin J, Dore GJ, O'Connell DL, et al. Cancer incidence in people with hepatitis B or C infection: a large community-based linkage study. J Hepatol. 2006;45:197-203.
6. Strauss R, Torner A, Duberg AS, Hultcrantz R, Ekdahl K. Hepatocellular carcinoma and other primary liver cancers in hepatitis C patients in Sweden - a low endemic country. J Viral Hepat. 2008;15: 531-537.
7. Matsuo K, Kusano A, Sugumar A, Nakamura S, Tajima K, Mueller NE. Effect of hepatitis C virus infection on the risk of non-Hodgkin's lymphoma: a meta-analysis of epidemiological studies. Cancer Sci. 2004; 95:745-752.
8. Schollkopf C, Smedby KE, Hjalgrim H, et al. Hepatitis C infection and risk of malignant lymphoma. Int J Cancer. 2008;122:1885-1890.
9. Dal ML, Franceschi S. Hepatitis C virus and risk of lymphoma and other lymphoid neoplasms: a meta-analysis of epidemiologic studies. Cancer Epidemiol Biomarkers Prev. 2006;15:2078-2085.
10. Gisbert JP, Garcia-Buey L, Pajares JM, Moreno-Otero R. Prevalence of hepatitis C virus infection in B-cell non-Hodgkin's lymphoma: systematic review and meta-analysis. Gastroenterology. 2003;125:1723-1732.
11. Cooper CL. Obstacles to successful HCV treatment in substance addicted patients. J Addict Dis. 2008;27:61-68.
12. Singal AK, Anand BS. Mechanisms of synergy between alcohol and hepatitis C virus. J Clin Gastroenterol. 2007;41:761-772.
13. Balsano C, Alisi A. Hepatitis C virus (HCV): an RNA virus with a pro-oncogenic potential. Dig Liver Dis. 2007;39 Suppl 1:S46-S51.
14. Craxi A, Laffi G, Zignego AL. Hepatitis C virus (HCV) infection: a systemic disease. Mol Aspects Med. 2008;29:85-95.
15. Blot WJ, McLaughlin JK, Winn DM, et al. Smoking and drinking in relation to oral and pharyngeal cancer. Cancer Res. 1988;48: 3282-3287.
16. Freedman ND, Leitzmann MF, Hollenbeck AR, Schatzkin A, Abnet CC. Cigarette smoking and subsequent risk of lung cancer in men and women: analysis of a prospective cohort study. Lancet Oncol. 2008;9: 649-656.
17. Hart AR, Kennedy H, Harvey I. Pancreatic cancer: a review of the evidence on causation. Clin Gastroenterol Hepatol. 2008;6:275-282.
18. Hashibe M, Brennan P, Benhamou S, et al. Alcohol drinking in never users of tobacco, cigarette smoking in never drinkers, and the risk of head and neck cancer: pooled analysis in the International Head and Neck Cancer Epidemiology Consortium. J Natl Cancer Inst. 2007;99:777-789.
19. Lipworth L, Tarone RE, McLaughlin JK. The epidemiology of renal cell carcinoma. J Urol. 2006;176:2353-2358.
20. Frank L. Epidemiology. When an entire country is a cohort. Science. 2000;287:2398-2399.
21. Andersen TF, Madsen M, Jorgensen J, Mellemkjoer L, Olsen JH. The Danish National Hospital Register. A valuable source of data for modern health sciences. Dan Med Bull. 1999;46:263-268.
22. Storm HH, Michelsen EV, Clemmensen IH, Pihl J. The Danish Cancer Registry - history, content, quality and use. Dan Med Bull. 1997;44:535-539.
23. Patel P, Hanson DL, Sullivan PS, et al. Incidence of types of cancer among HIV-infected persons compared with the general population in the United States, 1992-2003. Ann Intern Med. 2008;148: 728-736.
24. Grulich AE, van Leeuwen MT, Falster MO, Vajdic CM. Incidence of cancers in people with HIV/AIDS compared with immunosuppressed transplant recipients: a meta-analysis. Lancet. 2007;370:59-67.
25. Rothman KJ, Boice JD. Epidemiologic analyses with a programmable calculator. Department of Health and Human Services publication no 79-1649 (National Institutes of Health) 1979; Washington DC: Goverment Printing Office.
26. Rothman KJ. Analy z ing Simpl e Epidemiologi c Data. Epidemiology - An Introduction. 1st ed. New York: Oxford University Press; 2002:130-143.
27. Di M, V, Rufat P, Boyer N, et al. The influence of human immunodeficiency virus coinfection on chronic hepatitis C in injection drug users: a long-term retrospective cohort study. Hepatology. 2001;34: 1193-1199.
28. Mohsen AH, Easterbrook PJ, Taylor C, et al. Impact of human immunodeficiency virus (HIV) infection on the progression of liver fibrosis in hepatitis C virus infected patients. Gut. 2003;52:1035-1040.
29. Omland LH, Jepsen P, Skinhoj P, et al. The impact of HIV-1 co-infection on long-term mortality in patients with hepatitis C: a population-based cohort study. HIV Med. 2009;10:65-71.
30. Wiese M, Grungreiff K, Guthoff W, Lafrenz M, Oesen U, Porst H. Outcome in a hepatitis C (genotype 1b) single source outbreak in Germany - a 25-year multicenter study. J Hepatol. 2005;43: 590-598.
31. Obel N, Reinholdt H, Omland LH, Engsig F, Sorensen HT, Hansen AB. Retrivability in The Danish National Hospital Registry of HIV and hepatitis B and C coinfection diagnoses of patients managed in HIV centers 1995-2004. BMC Med Res Methodol. 2008;8:25.
32. The National Board of Health. Guide to the prevention of viral hepatitis [in Danish]. 2008
33. Lauer GM, Walker BD. Hepatitis C virus infection. N Engl J Med. 2001;345:41-52.
34. Rothman KJ. Biases in Study Design. Epidemiology - An Introduction. 1st ed. New York: Oxford University Press; 2002:94-112.
35. Sorensen HT, Mellemkjaer L, Skriver MV, et al. Fever of unknown origin and cancer: a population-based study. Lancet Oncol. 2005;6:851-855.
36. WHO. World Health Organization. Global status report on alcohol 2004 - Country Profiles. 2010
37. Lok AS, Seeff LB, Morgan TR, et al. Incidence of hepatocellular carcinoma and associated risk factors in hepatitis C-related advanced liver disease. Gastroenterology. 2009;136:138-148.
38. Freedman DS, Tolbert PE, Coates R, Brann EA, Kjeldsberg CR. Relation of cigarette smoking to non-Hodgkin's lymphoma among middle-aged men. Am J Epidemiol. 1998;148:833-841.
39. Morton LM, Hartge P, Holford TR, et al. Cigarette smoking and risk of non-Hodgkin lymphoma: a pooled analysis from the International Lymphoma Epidemiology Consortium (interlymph). Cancer Epidemiol Biomarkers Prev. 2005;14:925-933.
40. Morton LM, Zheng T, Holford TR, et al. Alcohol consumption and risk of non-Hodgkin lymphoma: a pooled analysis. Lancet Oncol. 2005;6:469-476.
41. Talamini R, Polesel J, Montella M, et al. Smoking and non-Hodgkin lymphoma: case-control study in Italy. Int J Cancer. 2005;115:606-610.
42. Amin J, Law MG, Bartlett M, Kaldor JM, Dore GJ. Causes of death after diagnosis of hepatitis B or hepatitis C infection: a large community- based linkage study. Lancet. 2006;368:938-945.
43. Du WJ, Xiang YT, Wang ZM, et al. Socio-demographic and clinical characteristics of 3129 heroin users in the first methadone maintenance treatment clinic in China. Drug Alcohol Depend. 2008;94:158-164